157 related articles for article (PubMed ID: 36894309)
41. Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT.
Devall A; Chu J; Beeson L; Hardy P; Cheed V; Sun Y; Roberts T; Ogwulu CO; Williams E; Jones L; Papadopoulos JF; Bender-Atik R; Brewin J; Hinshaw K; Choudhary M; Ahmed A; Naftalin J; Nunes N; Oliver A; Izzat F; Bhatia K; Hassan I; Jeve Y; Hamilton J; Deb S; Bottomley C; Ross J; Watkins L; Underwood M; Cheong Y; Kumar C; Gupta P; Small R; Pringle S; Hodge F; Shahid A; Gallos I; Horne A; Quenby S; Coomarasamy A
Health Technol Assess; 2021 Nov; 25(68):1-114. PubMed ID: 34821547
[TBL] [Abstract][Full Text] [Related]
42. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.
Abubeker FA; Lavelanet A; Rodriguez MI; Kim C
BMC Womens Health; 2020 Jul; 20(1):142. PubMed ID: 32635921
[TBL] [Abstract][Full Text] [Related]
43. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
Warden S; Genkin I; Hum S; Dunn S
J Obstet Gynaecol Can; 2019 May; 41(5):647-652. PubMed ID: 31007171
[TBL] [Abstract][Full Text] [Related]
44. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
Goldstone P; Michelson J; Williamson E
Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
[TBL] [Abstract][Full Text] [Related]
45. Medical abortion offered in pharmacy versus clinic-based settings: A systematic review.
Rodriguez MI; Edelman AB; Hersh A; Gartoulla P; Henderson JT
Contraception; 2021 Nov; 104(5):478-483. PubMed ID: 34175269
[TBL] [Abstract][Full Text] [Related]
46. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
47. Feasibility of telephone follow-up after medical abortion.
Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
[TBL] [Abstract][Full Text] [Related]
48. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group.
Winikoff B; Ellertson C; Elul B; Sivin I
Arch Fam Med; 1998; 7(4):360-6. PubMed ID: 9682690
[TBL] [Abstract][Full Text] [Related]
49. Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.
Schmidt-Hansen M; Cameron S; Lohr PA; Hasler E
Am J Obstet Gynecol; 2020 Jun; 222(6):551-563.e13. PubMed ID: 31715147
[TBL] [Abstract][Full Text] [Related]
50. Mifepristone and misoprostol for early abortion when no gestational sac is present.
Schaff EA; Fielding SL; Eisinger S; Stadalius L
Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
[TBL] [Abstract][Full Text] [Related]
51. Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives.
Crouthamel B; Pearson E; Tilford S; Hurst S; Paul D; Aqtar F; Silverman J; Averbach S
Reprod Health; 2021 Mar; 18(1):69. PubMed ID: 33766050
[TBL] [Abstract][Full Text] [Related]
52. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
[TBL] [Abstract][Full Text] [Related]
53. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
Creinin MD; Vittinghoff E; Keder L; Darney PD; Tiller G
Contraception; 1996 Jun; 53(6):321-7. PubMed ID: 8773418
[TBL] [Abstract][Full Text] [Related]
54. Could American women use mifepristone-misoprostol pills safely with less medical supervision?
Harper C; Ellertson C; Winikoff B
Contraception; 2002 Feb; 65(2):133-42. PubMed ID: 11927116
[TBL] [Abstract][Full Text] [Related]
55. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
[TBL] [Abstract][Full Text] [Related]
56. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
[TBL] [Abstract][Full Text] [Related]
57. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
58. Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19.
Reynolds-Wright JJ; Johnstone A; McCabe K; Evans E; Cameron S
BMJ Sex Reprod Health; 2022 Jul; 48(3):185-192. PubMed ID: 34711647
[TBL] [Abstract][Full Text] [Related]
59. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
[TBL] [Abstract][Full Text] [Related]
60. Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
Blum J; Karki C; Tamang A; Shochet T; Shrestha A; Tuladhar H; Karki A; Sharma J; Abbas DF; Dragoman M; Winikoff B
Contraception; 2019 Dec; 100(6):451-456. PubMed ID: 31491379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
